E. Celis

发表

Poly-ICLC, a multi-functional immune modulator for treating cancer.

H. Sultan, A. Salazar, E. Celis, 2020, Seminars in immunology.

Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration

H. Sultan, A. Salazar, E. Celis, 2020, Journal for ImmunoTherapy of Cancer.

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

G. Zhu, Lieping Chen, K. Tamada, 2002, Nature Medicine.

Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.

E. Celis, Hyun-Il Cho, 2009, Cancer research.

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

T. Padhya, E. Celis, Je-in Youn, 2010, The Journal of experimental medicine.

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

J. Sidney, H. Grey, A. Sette, 1993, Cell.

Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

A. Sette, F. Chisari, R. Chesnut, 1999, Journal of immunology.

Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.

A. Sette, J. Flynn, B. Bloom, 2000, Proceedings of the National Academy of Sciences of the United States of America.

T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy

P. Thevenot, E. Celis, D. Wyczechowska, 2016, Oncotarget.

Focal adhesion kinase as an immunotherapeutic target

H. Iizuka, M. Honma, E. Celis, 2009, Cancer Immunology, Immunotherapy.

Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors

T. Sayers, E. Celis, H. Yagita, 2010, Cancer Immunology, Immunotherapy.

Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4).

L. Otvos, E. Celis, J. Larson, 1990, Journal of immunology.

inducTION of mage‐A3 and HPV‐16 immunity by Trojan vaccines in patients with head and neck carcinoma

M. Suntharalingam, M. Tan, R. Hertzano, 2012, Head & neck.

Acknowledgement

D. Busch, H. Einsele, M. Dhodapkar, 1987, Hearing Research.

Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.

L. Otvos, E. Celis, D. Ou, 1988, Journal of immunology.

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.

H. Grey, A. Sette, R. Chesnut, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Identification of HER2/neu‐derived peptide epitopes recognized by gastric cancer‐specific cytotoxic T lymphocytes

A. Sette, E. Appella, R. Kiessling, 1998, International journal of cancer.

Immunogenicity of protein therapeutics and the interplay between tolerance and antibody responses.

E. Celis, M. D. Barbosa, 2007, Drug discovery today.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity

E. Davila, E. Celis, 2006 .

Multiepitope Trojan Antigen Peptide Vaccines for the Induction of Antitumor CTL and Th Immune Responses1

E. Appella, Y. Higashimoto, E. Celis, 2004, The Journal of Immunology.

Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies.

V. Zurawski, T. Chang, E. Celis, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model.

M. Pittelkow, S. Markovic, A. Kalaaji, 2010, Cytokine.

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

K. Ishibashi, E. Celis, T. Kumai, 2017, Cancer Immunology, Immunotherapy.

Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes

B. Arp, E. Celis, E. Mellins, 1990, Nature.

Anti-Tumor Activity Results in Enhanced CTL Responses with Together with Peptide / Protein Immunization Guanine-Containing Oligonucleotides Cytosine-Phosphorothiolated Repeated Administration

E. Celis, 2000 .

c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma

K. Ishibashi, E. Celis, T. Kumai, 2015, Oncoimmunology.

Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17–producing CD4+ T cells

M. Moorghen, A. Martner, E. Celis, 2015, The Journal of experimental medicine.

Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell‐based immunotherapy of colon cancer in CEA/HLA‐A2 transgenic mice

K. Foon, E. Celis, M. Bhattacharya‐Chatterjee, 2009, International journal of cancer.

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

K. Ishibashi, E. Celis, H. Takei, 2019, Journal of Translational Medicine.

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.

M. Sporn, S. Altiok, E. Celis, 2011, The Journal of clinical investigation.

Effective antitumor peptide vaccines can induce severe autoimmune pathology

H. Sultan, E. Celis, P. Rodriguez, 2017, Oncotarget.

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.

S. Altiok, E. Celis, D. Gabrilovich, 2010, The Journal of clinical investigation.

Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors

G. Niu, E. Celis, Hyun-Il Cho, 2008, Cancer Immunology, Immunotherapy.

Editorial: A matter of survival: HMGB1 regulates autophagy in tumor MDSC

E. Celis, P. Rodriguez, T. Kumai, 2016, Journal of leukocyte biology.

CancerCross-Presentation by Dendritic Cells in Oxidized Lipids Block Antigen

Judith, W. Cao, E. Celis, 2014 .

Canceron by Dendritic Cells in Oxidized Lipids Block Antigen

W. Cao, E. Celis, A. Amoscato, 2014 .

Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

J. Klein-Seetharaman, W. Cao, E. Celis, 2014, The Journal of Immunology.

Lipid accumulation and dendritic cell dysfunction in cancer

M. Fishman, T. Padhya, R. Ferris, 2007, Nature Medicine.

A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy.

E. Celis, Hyun-Il Cho, J. Delgado, 2012, Cancer research.

Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells

E. Celis, D. Gabrilovich, A. Schrum, 2010, The Journal of Immunology.

HBsAg‐Serum Protein Complexes Stimulate Immune T Lymphocytes More Efficiently Than Do Pure HBsAg

E. Celis, T. Chang, 1984, Hepatology.

In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine

V. Zurawski, E. Celis, Richard W. Miller, 1984, Hepatology.

Advances in Brief Tumor Prevention and Antitumor Immunity with Heat Shock Protein 70 Induced by 15-Deoxy-D 12 , 14-prostaglandin J 2 in Transgenic Adenocarcinoma of Mouse Prostate Cells 1

E. Celis, C. Young, D. K. Vanaja, 2000 .

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.

J. Prieto, B. Sangro, E. Huarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.

E. Appella, D. Hoon, E. Celis, 2001, Cancer research.

Avoiding Tolerance Against Prostatic Antigens With Subdominant Peptide Epitopes

E. Davila, E. Celis, M. Grossmann, 2001, Journal of immunotherapy.

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

J. Prieto, E. Huarte, J. Lasarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Identification of HLA‐A24 epitope peptides of carcinoembryonic antigen which induce tumor‐reactive cytotoxic T lymphocyte

A. Sette, I. Kato, E. Celis, 1999, International journal of cancer.

Carcinomas and Melanomas CTL Against Autologous and Allogeneic Peptide Epitopes That Can Elicit Specific Derived neu-Identification of New HER 2 /

O. Larsson, A. Sette, E. Appella, 1999 .

HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.

A. Sette, E. Celis, R. Shapiro, 1998, Journal of immunology.

Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer.

V. Tsai, R. Alexander, E. Celis, 1998, Urology.

Assay of peptide binding affinity to HLA-A * 0201

A. Sette, E. Celis, R. Shapiro, 1998 .

Epitope selection and development of peptide based vaccines to treat cancer.

H. Grey, A. Sette, E. Celis, 1995, Seminars in cancer biology.

Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation1

B. Leibovich, M. T. Moser, J. Allison, 2004, The Journal of Immunology.

In vitro induction of immune responses to shared tumor-associated antigens in rhabdomyosarcoma.

D. Rodeberg, E. Celis, C. Erskine, 2007, Journal of pediatric surgery.

Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.

E. Celis, Jun Lu, J. Lu, 2000, Cancer research.

Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen

J. Prieto, J. Lasarte, E. Celis, 2004, Clinical Cancer Research.

Epitope Specific for an MHC Class II Promiscuous T Cells + Lymphoproliferation by CD 4 Inhibition of EBV-Induced

C. Payá, E. Celis, R. Omiya, 2002 .

Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.

R. Kennedy, E. Celis, R. Giuntoli, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lymphocytes from Carcinoembryonic Antigen Identification of an Antigenic Epitope for Helper T Updated Version

J. Prieto, B. Sangro, E. Huarte, 2002 .

Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function.

R. Kennedy, E. Celis, R. Giuntoli, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Histocompatibility Complex Class II Alleles Promiscuous MAGE-A 3 Epitope Presented by Various Major Tumor-reactive T Helper Lymphocytes Recognize a Updated

E. Appella, D. Hoon, E. Celis, 2001 .

In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells.

A. Sette, V. Tsai, E. Celis, 1998, Critical reviews in immunology.

Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles.

J. Sidney, A. Sette, E. Celis, 1994, Molecular immunology.

Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.

J. Sidney, A. Sette, K. Sakaguchi, 1997, Journal of immunology.

Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24.

A. Sette, F. Tanaka, K. Tahara, 1997, Cancer research.

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

H. Grey, A. Sette, R. Chesnut, 1998, Vaccine.

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.

H. Grey, A. Sette, F. Chisari, 1995, Molecular immunology.

Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis.

A. Sette, E. Celis, R. Shapiro, 2000, Journal of immunological methods.

Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy

K. Ishibashi, E. Celis, T. Kumai, 2016, Oncoimmunology.

NF‐κB is crucial in proximal T‐cell signaling for calcium influx and NFAT activation

A. Beg, E. Celis, Xue-Zhong Yu, 2014, European journal of immunology.

Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53

K. Ishibashi, E. Celis, T. Kumai, 2014, Cancer Immunology, Immunotherapy.

Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition

H. Sultan, E. Celis, Juan Wu, 2018, Cancer Immunology Research.

Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition.

J. Janik, E. Celis, S. Khleif, 2017, Cancer research.

An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

K. Ozato, Dafeng Yang, Kebin Liu, 2018, The Journal of clinical investigation.

In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.

E. Celis, N. DeVito, Hyun-Il Cho, 2008, Cancer research.

Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease

Lieping Chen, L. Pease, K. Tamada, 2002 .

PKCθ Is Required For Alloreactivity And GVHD But Not For Immune Responses Toward Leukemia And Infection In Mice

M. Prlic, R. Engelman, M. Bevan, 2010 .

Peptide-induced proliferation and lymphokine production in human T cells in the absence of antigen-presenting cells: role of T-cell activation state and costimulatory signals.

E. Celis, T. Saibara, J. Goodwin, 1992, Human immunology.

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

H. Sultan, A. Salazar, E. Celis, 2019, Cancer Immunology, Immunotherapy.

Cancer immunotherapy: moving forward with peptide T cell vaccines.

E. Celis, Aaron E. Fan, T. Kumai, 2017, Current opinion in immunology.

Overcoming doubts and other obstacles in the development of effective peptide-based therapeutic vaccines against cancer

E. Celis, Hyun-Il Cho, 2010, Expert review of vaccines.

Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma

E. Celis, 2007, Cancer.

The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells

Loise M. Francisco, J. Wolchok, D. Munn, 2015, Journal of Immunotherapy for Cancer.

Recognition of Adult T-Cell Leukemia/Lymphoma Cells by CD4+ Helper T Lymphocytes Specific for Human T-Cell Leukemia Virus Type I Envelope Protein

M. Yanai, E. Celis, R. Omiya, 2004, Clinical Cancer Research.

Direct Cross-Priming by Th Lymphocytes Generates Memory Cytotoxic T Cell Responses1

Anita H. Undale, L. Pease, R. Kennedy, 2005, The Journal of Immunology.

Generates Memory Cytotoxic T Cell Direct Cross-Priming by Th Lymphocytes

Anita H. Undale, L. Pease, R. Kennedy, 2005 .

The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells

R. Karr, W. Yu, E. Celis, 1990, The Journal of experimental medicine.

Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Anita H. Undale, E. Celis, P. J. van den Elsen, 2004, International immunology.

Adoptive Transfer of Tc1 or Tc17 Cells Elicits Antitumor Immunity against Established Melanoma through Distinct Mechanisms

E. Celis, C. Anasetti, Xue-Zhong Yu, 2013, The Journal of Immunology.

MechanismsEstablished Melanoma through Distinct Elicits Antitumor Immunity against Adoptive Transfer of Tc1 or Tc17 Cells

E. Celis, C. Anasetti, Xue-Zhong Yu, 2013 .

Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2180–188-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2180–188 peptides

J. Sin, E. Celis, J. Choe, 2012, Cancer Immunology, Immunotherapy.

Double-Stranded RNA Immunomodulators in Prostate Cancer.

A. Salazar, E. Celis, 2020, The Urologic clinics of North America.

Vaccine-Elicited CD8+ T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c Mice

E. Celis, M. Moore, N. Lukacs, 2012, Journal of Virology.

Unpasteurized milk consumption and subsequent risk of cancer

J. Cerhan, R. Vierkant, T. Sellers, 2008, Cancer Causes & Control.

Functional analysis of MHC class II-restricted T cells derived from a Caucasian with a DR4, Dw15, DQw8 haplotype.

P. Gregersen, R. Karr, E. Celis, 1990, Human immunology.

Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.

K. Foon, E. Celis, M. Bhattacharya‐Chatterjee, 2007, Cancer research.

Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized mice

A. Tanaka, E. Celis, F. Tufaro, 2009, BMC complementary and alternative medicine.

MHC-Binding Peptides as Immunotherapeutics for Cancer

R. Kennedy, E. Davila, E. Celis, 2000, Immunological investigations.

Role of dendritic cell‐mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw

M. Elsalanty, C. Cutler, H. Sultan, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy

E. Celis, T. Kumai, Y. Harabuchi, 2013, British Journal of Cancer.

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer

E. Celis, T. Kumai, Hiroya Kobayashi, 2011, Journal of Translational Medicine.

Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.

M. Takahara, E. Celis, Y. Harabuchi, 2008, Cancer research.

In vitro Peptide Immunization of Target Tax Protein Human T-Cell Leukemia Virus Type 1–Specific CD4+ Helper T Lymphocytes

Yuetsu Tanaka, E. Celis, Hiroya Kobayashi, 2006, Clinical Cancer Research.

Defining MHC class II T helper epitopes for WT1 tumor antigen

E. Celis, T. Nagato, Hiroya Kobayashi, 2006, Cancer Immunology, Immunotherapy.

Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule

R. Karr, E. Celis, Esteban CELISlt, 1989, Journal of virology.

Binding of T cell receptor to major histocompatibility complex class II‐peptide complexes at the single‐cell level results in the induction of antigen unresponsiveness (anergy)

T. Saibara, E. Celis, 1992, European journal of immunology.

Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.

T. Chang, E. Celis, P. Kung, 1984, Journal of Immunology.

B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cells.

L. Pease, E. Celis, S. Radhakrishnan, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses

H. Sultan, E. Celis, Hyun-Il Cho, 2016, Cancer Immunology Research.

Transcutaneous Immunization with Cytotoxic T-Cell Peptide Epitopes Provides Effective Antitumor Immunity in Mice

E. Celis, T. Itoh, 2005, Journal of immunotherapy.

Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.

A. Sette, K. Tahara, E. Celis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Peptide Vaccination of Patients With Metastatic Melanoma: Improved Clinical Outcome in Patients Demonstrating Effective Immunization

J. Ingle, C. Loprinzi, H. Pitot, 2006, American journal of clinical oncology.

Toll-like receptor ligands energize peptide vaccines through multiple paths.

E. Celis, 2007, Cancer research.

Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy.

L. Montaner, D. Speicher, C. Meyer, 2022, Cancer cell.

Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins.

L. Otvos, L. Otvos, H. Wang, 1987, Virus research.

Induced by Androgen Deprivation Augmentation of T Cell Levels and Responses

M. T. Moser, J. Allison, A. Roden, 2004 .

Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. I. Changes in reactivity with cytotoxic T lymphocytes and anti-H-2d sera.

J. Russell, E. Celis, H. Eisen, 1979, Journal of immunology.

Interactions between a novel cell surface glycoprotein and the H‐2K and H‐2D antigens on myeloma tumor cells

E. Celis, H. N. Eisen, 1980 .

CELLULAR RECOGNITION IN TUMOR IMMUNOLOGY: TUMOR RESISTANCE TO IMMUNE DESTRUCTION BY CYTOTOXIC T LYMPHOCYTES

E. Celis, 1980 .

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy

M. Takahara, K. Kishibe, K. Ishibashi, 2017, Cancer Immunology, Immunotherapy.

Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.

Lieping Chen, L. Pease, K. Tamada, 2002, The Journal of clinical investigation.

Regulation of the human immune response to HBsAg: Effects of antibodies and antigen conformation in the stimulation of helper T cells by HBsAg

E. Celis, Richard W. Miller, T. Chang, 1985, Hepatology.

Rabies virus-specific T cell hybridomas: identification of class II MHC-restricted T-cell epitopes using synthetic peptides.

L. Otvos, E. Celis, H. Koprowski, 1989, Hybridoma.

PRDM1/Blimp-1 Controls Effector Cytokine Production in Human NK Cells

M. Caligiuri, Sheng Wei, K. Wright, 2010, The Journal of Immunology.

Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment.

E. Davila, E. Celis, C. Heppelmann, 2002, Blood.

T Helper Lymphocytes Rescue CTL from Activation-Induced Cell Death1

R. Kennedy, E. Celis, 2006, The Journal of Immunology.

A novel combinatorial cancer immunotherapy

E. Celis, T. Nagato, 2014, Oncoimmunology.

Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer

J. Klein-Seetharaman, D. Weiner, M. Murphy, 2017, Nature Communications.

Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen.

E. Celis, T. Chang, 1984, Science.

Modulation of the immunological response to hepatitis b virus by antibodies

E. Celis, Richard W. Miller, K. Abraham, 1987, Hepatology.

Antigen-induced production of lymphokines by human T cell clones specific for hepatitis B surface antigen.

T. Chang, E. Celis, R. Miller, 1984, Human immunology.

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma

M. Takahara, K. Kishibe, E. Celis, 2015, Cancer Immunology, Immunotherapy.

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.

C. Rupprecht, H. Ertl, E. Celis, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients

E. Celis, H. Koprowski, B. Dietzschold, 1988, Journal of virology.

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

S. Enkemann, E. Haura, A. Beg, 2013, The Journal of clinical investigation.

Effect of O2, ergosterol and sterol precursors on the mating ability of Kluyveromyces lactic.

E. Celis, J. Mas, A. Brunner, 1974, Biochemical and biophysical research communications.

Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.

F. Marincola, E. Trimble, A. Sette, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells.

A. Sette, E. Appella, R. Kiessling, 1997, Cancer research.

Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

A Sette, O. Larsson, A. Sette, 1999, Journal of immunology.

Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines

E. Celis, M. Grossmann, M. Wood, 2001, World Journal of Urology.

Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

E. Celis, D. Morse, J. Vagner, 2012, Journal of medicinal chemistry.

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

A. Sette, E. Appella, V. Tsai, 1998, Human immunology.

Effects of the extent of DNP substitution on the apparent affinity constant and cooperation between sites in the reactions of dinitrophenylated human serum albumin with anti-DNP and anti-HSA antibodies coupled to agarose.

E. Celis, C. Larralde, R. Ridaura, 1977, Immunochemistry.

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Haidong Dong, Gefeng Zhu, G. Zhu, 2002, Nature Medicine.

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells

J. Thompson, D. Byrd, S. Riddell, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

C Crimi, R W Chesnut, A Sette, 1996, International immunology.

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

J. Berzofsky, C. Rice, A. Sette, 1995, Journal of virology.

Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma

D. Rodeberg, E. Celis, C. Heppelmann, 2005, Cancer Immunology, Immunotherapy.

Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.

E. Celis, Jun Lu, H Kobayashi, 2001, Cancer research.

Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.

E. Appella, E. Celis, E Appella, 2000, Cancer research.

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.

N. Hockstein, W. El-Deiry, E. Celis, 2014, The Journal of clinical investigation.

Characterization of human CD4 helper T cell responses against Aurora kinase A

H. Kakizaki, E. Celis, Y. Harabuchi, 2010, Cancer Immunology, Immunotherapy.

H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells

Kebin Liu, E. Celis, T. Kumai, 2018, Oncoimmunology.

Designing therapeutic cancer vaccines by mimicking viral infections

H. Sultan, A. Salazar, E. Celis, 2017, Cancer Immunology, Immunotherapy.

Substitutions in the HLA-DR alpha chain differentially affect DR7-restricted T-cell recognition of rabies virus antigen.

R. Karr, E. Celis, T. Saibara, 1996, Human immunology.

Analysis of MHC-Specific Peptide Motifs

A. Sette, K. Sakaguchi, E. Appella, 1995 .

Peptide vaccines in cancer-old concept revisited.

E. Celis, T. Kumai, Y. Harabuchi, 2017, Current opinion in immunology.

The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment

Loise M. Francisco, J. Wolchok, D. Munn, 2015, Science Advances.

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

M. Wicha, A. Arbab, J. Cowell, 2019, Nature Communications.

Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice

H. Sultan, A. Salazar, E. Celis, 2018, Cancer Immunology, Immunotherapy.

Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.

A. Sette, V. Tsai, E. Celis, 1999, Cancer research.

Identification of HLA-A 3-restricted Cytotoxic T Lymphocyte Epitopes from Carcinoembryonic Antigen and HER-2 / neu by Primary in Vitro Immunization with Peptide-pulsed Dendritic Cells 1

A. Sette, V. Tsai, E. Celis, 1999 .

Functional Analysis of Birch Pollen Allergen Bet v 1-Specific Regulatory T Cells1

M. Yanai, E. Celis, Y. Harabuchi, 2007, The Journal of Immunology.

Consensus nomenclature for CD 8 T cell phenotypes in cancer

S. H. van der Burg, J. Blay, F. Marincola, 2015 .

Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. III. Periodic production of a cell surface glycoprotein and changes in reactivity with cytotoxic T cells and anti-H-2d sera.

T. Chang, E. Celis, H. Eisen, 1979, Journal of immunology.

Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor

E. Celis, T. Kumai, Y. Harabuchi, 2014, Journal of Translational Medicine.

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma

E. Celis, T. Kumai, Y. Harabuchi, 2015, Scientific Reports.

Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.

C. Rupprecht, E. Celis, H. Koprowski, 1987, The Journal of infectious diseases.

Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.

H. Kakizaki, H. Iizuka, E. Celis, 2007, Cancer research.

Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization.

T. Merigan, A. Sette, M. Eibl, 1998, AIDS research and human retroviruses.

Affinity 0201-Binding * Correlates with HLA-A Recognition of Naturally Processed Epitopes Different Tumor-Associated Antigens: Identification of New Epitopes from Four

A. Sette, R. Chesnut, E. Celis, 2001 .

Epitopes by Trojan Antigens TAP-Independent Presentation of CTL

E. Appella, Y. Higashimoto, E. Celis, 2001 .

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

A. Vitiello, H. Grey, A. Sette, 1995, Pharmaceutical biotechnology.

Genetic restriction and fine specificity of human T cell clones reactive with rabies virus.

R. Karr, E. Celis, H. Koprowski, 1988, Journal of immunology.

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein ( rabies vaccine / antigen priming / intrastructural antigen recognition / virus-neutralizing antibody / cytolytic T cells )

C. Rupprecht, H. Ertl, E. Celis, 2003 .

Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma.

E. Celis, H. Koprowski, R. Miller, 1986, Journal of immunology.

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

M F del Guercio, R W Chesnut, A Sette, 1996, Human immunology.

Bet v 1-Specific Regulatory T Cells Functional Analysis of Birch Pollen Allergen

M. Yanai, E. Celis, Y. Harabuchi, 2006 .

Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors

E. Celis, Y. Harabuchi, T. Nagato, 2014, Clinical Cancer Research.

Cancer Therapy : Preclinical Combinatorial Immunotherapy of Polyinosinic – Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD 8 T-cell Responses against Established Tumors

E. Celis, Y. Harabuchi, T. Nagato, 2014 .

Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope.

A. Sette, S. Rosenberg, M. Salgaller, 1996, American journal of obstetrics and gynecology.

Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

David M. Woods, D. Woods, K. Smalley, 2015, Molecular oncology.

A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma.

E. Celis, J. Weber, V. Marty, 1999, Journal of immunotherapy.

Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.

Yan Cui, Gang Guo, E. Celis, 2017, Cancer research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Multiple roles for CD4+ T cells in anti‐tumor immune responses

R. Kennedy, E. Celis, 2008, Immunological reviews.

T-cell epitope peptide vaccines

Sherine F. Elsawa, D. Rodeberg, E. Celis, 2004, Expert review of vaccines.

Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy.

S. Altiok, E. Celis, D. Gabrilovich, 2012, Cancer research.

Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma

M. Takahara, K. Kishibe, E. Celis, 2020, Oncoimmunology.

BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses

K. Barrios, E. Celis, Hyun-Il Cho, 2013, Cancer Immunology, Immunotherapy.

Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.

R. Kennedy, E. Davila, E. Celis, 2003, Cancer research.

Repeated Administration of Cytosine-Phosphorothiolated Guanine-Containing Oligonucleotides Together with Peptide/Protein Immunization Results in Enhanced CTL Responses with Anti-Tumor Activity1

E. Davila, E. Celis, 2000, The Journal of Immunology.

An optimized peptide vaccine strategy capable of inducing multivalent CD8+ T cell responses with potent antitumor effects

E. Celis, Hyun-Il Cho, Tai-Gyu Kim, 2015, Oncoimmunology.

Interferon γ limits the effectiveness of melanoma peptide vaccines.

E. Celis, Hyun-Il Cho, Young-Ran Lee, 2011, Blood.

Antibodies and Vaccines as Novel Cancer Therapeutics

S. Markovic, E. Celis, 2006 .

Rabies experiment

C. Rupprecht, E. Celis, H. Koprowski, 1987, Nature.

Challenges in the development of effective peptide vaccines for cancer.

S. Markovic, E. Celis, Svetomir N Markovic, 2002, Mayo Clinic proceedings.

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

M F del Guercio, R W Chesnut, A Sette, 1995, Journal of immunology.

STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice

Zili Wang, E. Celis, 2015, Cancer Immunology, Immunotherapy.

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.

A. Sette, G. Fleuren, C. Melief, 1996, Cancer research.

Recognition of Prostate and Breast Tumor Cells by Helper T Lymphocytes Specific for a Prostate and Breast Tumor-Associated Antigen, TARP

E. Celis, R. Omiya, T. Nagato, 2005, Clinical Cancer Research.

Getting peptide vaccines to work: just a matter of quality control?

E. Celis, 2002, The Journal of clinical investigation.

Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma

H. Grey, A. Sette, G. Fleuren, 2000, Journal of immunotherapy.

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes

John Sidney, Scott Southwood, Akihiro Kondo, 1997, Immunogenetics.

CD4 T Cells in Antitumor Immunity

H. Sultan, E. Celis, V. Fesenkova, 2016 .

Induced by Myeloid-Derived Mechanism of T Cell Tolerance

E. Celis, D. Gabrilovich, A. Schrum, 2010 .

Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors.

L. Pease, G. Forni, E. Celis, 2007, Cancer research.

Inhibition of EBV-Induced Lymphoproliferation by CD4+ T Cells Specific for an MHC Class II Promiscuous Epitope1

Hiroya Kobayashi, C. Payá, E. Celis, 2002, The Journal of Immunology.

Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells

E. Celis, Hiroya Kobayashi, Keisuke Sato, 2001, Immunogenetics.

Identification of α‐fetoprotein‐specific T‐cell receptors for hepatocellular carcinoma immunotherapy

Juan Wu, Wei Zhu, Qi Li, 2018, Hepatology.

Generation of tumoricidal PAX3 peptide antigen specific cytotoxic T lymphocytes

Sherine F. Elsawa, D. Rodeberg, E. Celis, 2006, International journal of cancer.

Recognition of Six-Transmembrane Epithelial Antigen of the Prostate–Expressing Tumor Cells by Peptide Antigen–Induced Cytotoxic T Lymphocytes

Sherine F. Elsawa, D. Rodeberg, E. Celis, 2005, Clinical Cancer Research.

Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen.

E. Celis, Jun Lu, 2002, Cancer research.

Peptide Vaccines for Cancer

E. Celis, 2017 .

Peptide epitope identification for tumor-reactive CD4 T cells.

E. Celis, Hiroya Kobayashi, 2008, Current opinion in immunology.

Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. II. Periodic fluctuations during growth in normal and nude mice and in culture.

J. Russell, E. Celis, H. Eisen, 1979, Journal of immunology.

Vaccine-Elicited CD 8 + T Cells Protect against Respiratory Syncytial Virus Strain A 2-Line 19 F-Induced Pathogenesis in BALB / c Mice

E. Celis, N. Lukacs, K. Sakamoto, 2022 .

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

K. Barrios, E. Celis, 2012, Cancer Immunology, Immunotherapy.

Design of immunogenic and effective multi-epitope DNA vaccines for melanoma

E. Celis, Hyun-Il Cho, 2012, Cancer Immunology, Immunotherapy.

A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope

E. Celis, T. Kumai, Hiroya Kobayashi, 2012, Cancer Immunology, Immunotherapy.

A reproducible method for the enumeration of functional (cytokine producing) versus non‐functional peptide‐specific cytotoxic T lymphocytes in human peripheral blood

S. Markovic, E. Celis, W. Nevala, 2006, Clinical and experimental immunology.

Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells.

E. Celis, C. Young, D. K. Vanaja, 2000, Cancer research.

Identification of naturally processed helper T-cell epitopes from prostate-specific membrane antigen using peptide-based in vitro stimulation.

S. Senju, Y. Nishimura, M. Yanai, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Transnuclear TRP1-Specific CD8 T Cells with High or Low Affinity TCRs Show Equivalent Antitumor Activity

R. Jaenisch, H. Ploegh, E. Celis, 2013, Cancer Immunology Research.

Transnuclear TRP 1-specific CD 8 T cells with high or low affinity TCRs show equivalent anti-tumor activity

R. Jaenisch, H. Ploegh, E. Celis, 2014 .

Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides.

E. Celis, J. Baines, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma

K. Ishibashi, E. Celis, T. Kumai, 2018, Oncoimmunology.

Crawling movements of lymphocytes on and beneath fibroblasts in culture.

T. Chang, E. Celis, H. Eisen, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer

J. Klein-Seetharaman, D. Weiner, M. Murphy, 2017, Nature Communications.

Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies

E. Celis, H. Koprowski, B. Dietzschold, 1985, Journal of virology.

Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery

M. Takahara, K. Kishibe, E. Celis, 2021, Cancer Immunology, Immunotherapy.

Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor

E. Celis, T. Kumai, Y. Harabuchi, 2014, Journal of Translational Medicine.

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

M. Wicha, A. Arbab, J. Cowell, 2019, Nature Communications.

Correction: Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

J. Klein-Seetharaman, W. Cao, E. Celis, 2014, The Journal of Immunology.

Abstract 3226: The IRF8-osteopontin-CD44 axis functions as an immune checkpoint to control CD8+ T cell activation and tumor immune evasion

K. Ozato, Dafeng Yang, Kebin Liu, 2019, Immunology.

compartmentexpansion of naive and memory T lymphocytes in a full T-cell Creating space : an antigen-independent , CpG-induced peripheral

E. Davila, E. Celis, C. Heppelmann, 2002 .

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

K. Ishibashi, E. Celis, H. Takei, 2019, Journal of translational medicine.

Cytoplasmic and nuclear inheritance of resistance to alkylguanidines and ethidium bromide in a petite-negative yeast.

J. Mattoon, E. Celis, J. Mas, 1973, Biochemical and Biophysical Research Communications - BBRC.

Nuclear and cytoplasmic cross-resistance and correlated sensitivity to DNA intercalating drugs in a petite-negative yeast

E. Celis, J. Mas, A. Brunner, 1975 .

Ethidium bromide uptake and change of fluorescence by petite‐negative yeast mutants resistant to this drug

E. Celis, J. Mas, A. Brunner, 1975, FEBS letters.

ROLE FOR MONOCLONAL HEPATITIS B ANTIBODY IN HEPATITIS B IMMUNISATION PROGRAMMES

E. Celis, R. Tiebout, W. Zeijlemaker, 1985, The Lancet.

Avoiding Tolerance Against Prostatic Antigens With Subdominant Peptide Epitopes.

E. Davila, E. Celis, M. Grossmann, 2001, Journal of immunotherapy.

Synthetic antigenic peptides as a new strategy for immunotherapy of cancer.

A. Sette, K. Sakaguchi, E. Appella, 1995, Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity.

Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine (2002) 8 (793-800))

G. Zhu, Lieping Chen, K. Tamada, 2002 .

Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents.

A. Melcher, R. Vile, H. Pandha, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.